Pharmacokinetics and Pharmacodynamics of Single Doses of Rivaroxaban in Obesity Patients Before and After Bariatric Surgery

Trial Profile

Pharmacokinetics and Pharmacodynamics of Single Doses of Rivaroxaban in Obesity Patients Before and After Bariatric Surgery

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Jan 2017

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Venous thromboembolism
  • Focus Pharmacokinetics
  • Most Recent Events

    • 25 Jan 2017 Results published in the British Journal of Clinical Pharmacology
    • 07 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Jun 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top